Day One Biopharmaceuticals, Inc. (DAWN) — key financial figures for fiscal year 2025 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2025)

$158.2M

Net Income/Loss (FY2025)

-$107.3B

Total Assets (FY2025)

$507.8M

Total Equity (FY2025)

$441.2M

Cash Flows from Operating Activities (FY2025)

-$103.8M

Source: Day One Biopharmaceuticals, Inc. 10-K/A filing (FY2025). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.